This Long-term follow-up is designed to evaluate the safety of patient with Alcoholic Liver Cirrhosis who had administered Cellgram-LC in PMC-P-07 study.
To evaluate the safety for 60 months after a single dose of Cellgram-LC in patients with alcoholic liver cirrhosis.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
100
Patients who had administered Cellgram-LC in PMC-P-07 study
Soonchunhyang University Hospital
Bucheon-si, South Korea
RECRUITINGSoonchunhyang University Hospital
Cheonan, South Korea
RECRUITINGRate of AESI
death, neoplasms or malignancies in tissues or organs, Immune response including exacerbation or new outbreaks of previous autoimmune diseases, Other delayed AE related to Cellgram LC)
Time frame: For 5 years
Rate of Liver transplant
Liver transplant
Time frame: For 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Gangwon National University Hospital
Chuncheon, South Korea
RECRUITINGHallym Univ. Medical Center
Chuncheon, South Korea
RECRUITINGGangneung Asan Hospital
Gangneung-si, South Korea
RECRUITINGEunpyeong St. Mary's Hospital
Seoul, South Korea
RECRUITINGKorea University Anam Hospital
Seoul, South Korea
RECRUITINGSeoul National University Hospital
Seoul, South Korea
RECRUITINGSoonchunhyang University Hospital
Seoul, South Korea
RECRUITINGWonju Severance Christian Hospital
Wŏnju, South Korea
RECRUITING...and 1 more locations